Callan Family Office LLC Cuts Holdings in Colgate-Palmolive Company $CL

Callan Family Office LLC decreased its position in Colgate-Palmolive Company (NYSE:CL) by 37.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,702 shares of the company’s stock after selling 6,983 shares during the period. Callan Family Office LLC’s holdings in Colgate-Palmolive were worth $935,000 as of its most recent filing with the SEC.

Other hedge funds have also recently modified their holdings of the company. Asset Management One Co. Ltd. raised its position in shares of Colgate-Palmolive by 3.9% in the third quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock worth $33,758,000 after buying an additional 16,017 shares in the last quarter. Cidel Asset Management Inc. increased its stake in Colgate-Palmolive by 13.6% in the 2nd quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock worth $29,912,000 after acquiring an additional 39,413 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Colgate-Palmolive by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock valued at $7,522,129,000 after acquiring an additional 993,432 shares in the last quarter. TD Waterhouse Canada Inc. boosted its position in shares of Colgate-Palmolive by 248.5% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock valued at $6,909,000 after acquiring an additional 62,327 shares during the last quarter. Finally, Sequoia Financial Advisors LLC boosted its position in shares of Colgate-Palmolive by 18.6% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock valued at $2,752,000 after acquiring an additional 4,738 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL stock opened at $94.84 on Friday. The firm has a market cap of $76.45 billion, a P/E ratio of 36.20, a P/E/G ratio of 4.27 and a beta of 0.29. The firm’s fifty day moving average is $81.86 and its 200 day moving average is $81.60. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.91 earnings per share. Research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be given a $0.52 dividend. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 annualized dividend and a yield of 2.2%. Colgate-Palmolive’s payout ratio is presently 79.39%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CL shares. Raymond James Financial lowered their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Jefferies Financial Group increased their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a report on Monday. TD Cowen reaffirmed a “buy” rating on shares of Colgate-Palmolive in a report on Monday. Evercore ISI increased their target price on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday. Finally, UBS Group raised their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research report on Wednesday, January 14th. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $94.47.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.